header-logos-en.inc
Fact Sheet 2008
| Chairman and CEO | Daniel Vasella, M.D. |
| Headquarters | Basel, Switzerland |
| Major R&D sites | Basel, Switzerland |
| Cambridge, Massachusetts | |
| East Hanover, New Jersey | |
| Horsham, England | |
| Shanghai, China |
| Major production sites | Basel, Switzerland |
| Grimsby, England | |
| Huningue, France | |
| Kundl, Austria | |
| Kurtkoy, Turkey | |
| Lincoln, Nebraska | |
| Ringaskiddy, Ireland | |
| Ringaskiddy, Ireland | |
| Schaftenau, Austria | |
| Schweizerhalle, Switzerland | |
| Singapore | |
| Stein, Switzerland | |
| Suffern, New York, US |
| Web site address | www.novartis.com |
| Stock exchange listings | SIX Swiss Exchange, traded on SWX Europe (NOVN.VX) |
| New York Stock Exchange (NVS) | |
| 2008 net sales | USD 41.5 billion |
| Pharmaceuticals | USD 26.3 billion |
| Vaccines and Diagnostics | USD 1.8 million |
| Sandoz | USD 7.6 billion |
| Consumer Health | USD 5.8 billion |
| 2008 R&D spending | USD 7.2 billion |
| Pharmaceuticals | USD 5.7 billion |
| Vaccines and Diagnostics | USD 0.4 billion |
| Sandoz | USD 0.7 billion |
| Consumer Health | USD 0.3 billion |
| Corporate | USD 0.1 billion |
| 2008 full-time associates | 96 717 |
| Pharmaceuticals | 53 632 |
| Vaccines and Diagnostics | 4 774 |
| Sandoz | 23 146 |
| Consumer Health | 13 014 |
| Corporate | 2 151 |
OVER NOVARTIS
Op 7 maart 1996 gaan Sandoz en Ciba samen en vormen Novartis, waarmee een van de grootste fusies in de geschiedenis tot stand is gekomen. Onze naam, die is afgeleid van het Latijnse novae artes, betekent 'nieuwe vaardigheden' en weerspiegelt onze toewijding om nieuwe medicijnen voor de gezondheidszorg bij patiënten en artsen overal ter wereld te brengen.